Home »  In the Press » PRESS RELEASES 2008 » 2007 » 2006 » 2005 »  2004 »  2003 Tranzyme Pharma Appoints New Vice President of Clinical and Regulatory Affairs » September 20, 2005 Tranzyme Pharma’s Ghrelin Agonist Demonstrates a Unique Selectivity Profile for the Treatment of Gastrointestinal Disorders » July 6, 2005 FierceBiotech Honors Tranzyme Pharma as One of the “Fierce 15" Biotech Companies of 2005 » June 21, 2005 Tranzyme Pharma Presents Positive Preclinical Efficacy Data for its Lead GI Therapeutic, TZP-101 » May 19, 2005 Tranzyme Pharma Completes US$32 Million Financing » May 13, 2005